Evidence map›Paper›PMID 35485491›Full record

ArticleBrain : a journal of neurology2023

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson's disease.

Nicola J Ray, Rachael A Lawson, Sarah L Martin, Hilmar P Sigurdsson, Joanna Wilson, Brook Galna, Sue Lord, Lisa Alcock, Gordon W Duncan, Tien K Khoo and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Advanced brain aging, selective vulnerability in gray matter, and cognition in Parkinson's disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 4 countries.

Nicola J RayHealth, Psychology and Communities Research Centre, Department of Psychology, Manchester Metropolitan University, Manchester, UK.ORCID 0000-0001-9645-0812
Rachael A LawsonTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Sarah L MartinHealth, Psychology and Communities Research Centre, Department of Psychology, Manchester Metropolitan University, Manchester, UK.
Hilmar P SigurdssonTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-0624-065X
Joanna WilsonTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Brook GalnaTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Sue LordAuckland University of Technology, Auckland, New Zealand.
Lisa AlcockTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Gordon W DuncanCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Tien K KhooSchool of Medicine & Dentistry, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
John T O'BrienDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0837-5080
David J BurnPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
John-Paul TaylorTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
River C ReaHealth, Psychology and Communities Research Centre, Department of Psychology, Manchester Metropolitan University, Manchester, UK.
Maurizio BergaminoBarrow Neurological Institute, Neuroimaging Research, Phoenix, AZ, USA.
Lynn RochesterTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Alison J YarnallTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Newcastle University · GBManchester Metropolitan University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBAuckland University of Technology · NZBarrow Neurological Institute · USGriffith University · AUMurdoch University · AUNHS Lothian · GBUniversity of Cambridge · GB

Funding

Department of HealthWellcome Trust
6 · The paper itself

Abstract

Free-water imaging can predict and monitor dopamine system degeneration in people with Parkinson's disease. It can also enhance the sensitivity of traditional diffusion tensor imaging (DTI) metrics for indexing neurodegeneration. However, these tools are yet to be applied to investigate cholinergic system degeneration in Parkinson's disease, which involves both the pedunculopontine nucleus and cholinergic basal forebrain. Free-water imaging, free-water-corrected DTI and volumetry were used to extract structural metrics from the cholinergic basal forebrain and pedunculopontine nucleus in 99 people with Parkinson's disease and 46 age-matched controls. Cognitive ability was tracked over 4.5 years. Pearson's partial correlations revealed that free-water-corrected DTI metrics in the pedunculopontine nucleus were associated with performance on cognitive tasks that required participants to make rapid choices (behavioural flexibility). Volumetric, free-water content and DTI metrics in the cholinergic basal forebrain were elevated in a sub-group of people with Parkinson's disease with evidence of cognitive impairment, and linear mixed modelling revealed that these metrics were differently associated with current and future changes to cognition. Free water and free-water-corrected DTI can index cholinergic degeneration that could enable stratification of patients in clinical trials of cholinergic interventions for cognitive decline. In addition, degeneration of the pedunculopontine nucleus impairs behavioural flexibility in Parkinson's disease, which may explain this region's role in increased risk of falls.

Indexed as

Basal ForebrainParkinson DiseasePedunculopontine Tegmental NucleusCholinergic AgentsCholinergic NeuronsDiffusion Tensor ImagingHumansWaterCholinergic AgentsWatercholinergic systemcognitive declinefree-water imagingnucleus basalis of Meynertpedunculopontine nucleus

Identifiers

PMID35485491
PMCPMC9976974
OpenAlexW4225127155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.